Page last updated: 2024-11-07

4-fluorotryptophan

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-fluorotryptophan is a synthetic analogue of tryptophan. It is a fluorinated amino acid that has been studied as a potential therapeutic agent for a variety of diseases. 4-fluorotryptophan has been shown to inhibit the growth of cancer cells and to have antidepressant effects. It has also been studied as a potential treatment for Huntington's disease and other neurodegenerative disorders. The synthesis of 4-fluorotryptophan typically involves the fluorination of tryptophan using a variety of reagents, such as N-fluorobenzenesulfonimide or Selectfluor. The compound is then purified and characterized using standard techniques. 4-fluorotryptophan is studied because it has unique pharmacological properties that make it a promising candidate for the development of new drugs. For example, 4-fluorotryptophan is a potent inhibitor of the enzyme indoleamine 2,3-dioxygenase (IDO), which is involved in the degradation of tryptophan. Inhibition of IDO has been shown to have a number of therapeutic effects, including anti-inflammatory, anti-tumor, and antidepressant effects. In addition, 4-fluorotryptophan is a substrate for the enzyme tryptophan hydroxylase, which is involved in the synthesis of serotonin. This suggests that 4-fluorotryptophan may be able to modulate serotonin levels in the brain, which could have therapeutic implications for a variety of diseases.'

4-fluorotryptophan: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID101198
CHEMBL ID4078473
SCHEMBL ID1727642
SCHEMBL ID18029333
MeSH IDM0117964

Synonyms (27)

Synonym
4-fluoro-d,l-tryptophan
nsc529108
nsc-529108
25631-17-8
4-fluoro-dl-tryptophan, crystalline
F-6800
4-fluoro-dl-tryptophan
4-fluorotryptophan
25631-05-4
2-amino-3-(4-fluoro-1h-indol-3-yl)propanoic acid
A817932
tryptophan, 4-fluoro-
nsc 529108
FT-0618531
AKOS022929311
SCHEMBL1727642
SCHEMBL18029333
mfcd00039689
DTXSID30275961
h-trp(4-f)-oh
FS-6606
A50405
2-amino-3-(4-fluoro-1h-indol-3-yl)propanoicacid
CHEMBL4078473
EN300-369983
CS-0186533
PD042105
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (21.05)18.7374
1990's7 (36.84)18.2507
2000's4 (21.05)29.6817
2010's3 (15.79)24.3611
2020's1 (5.26)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 16.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index16.79 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.61 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (16.79)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]